Keyphrases
Gene Therapy
100%
Adenovirus
100%
Ovarian Carcinoma
100%
Flt-1
100%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
85%
Ovarian Tumor
57%
Tumor Growth
42%
Human Umbilical Vein Endothelial Cells (HUVECs)
28%
Green Fluorescent Protein
28%
SKOV3
28%
Survival Duration
28%
Murine Model
14%
Two-dose
14%
SCID Mice
14%
Tumor Model
14%
Therapeutic Potential
14%
Inoculation
14%
Endothelial Cell Proliferation
14%
Infectivity
14%
Survival Time
14%
Nude Mice
14%
Recombinant Adenovirus
14%
Ovarian Carcinoma Cells
14%
Functional Validation
14%
Inhibition Assay
14%
Tumor Nodule
14%
Cell Proliferation Inhibition
14%
Fms-like Tyrosine Kinase Receptor
14%
Medicine and Dentistry
Gene Therapy
100%
Krukenberg Tumor
100%
Adenoviridae
100%
Ovarian Tumor
50%
Tumor Progression
37%
Green Fluorescent Protein
25%
Human Umbilical Vein Endothelial Cell
25%
Neoplasm
12%
Infection
12%
In Vitro
12%
Cell Proliferation
12%
Ex Vivo
12%
SCID Mouse
12%
Tumor Model
12%
Vasculotropin Receptor 1
12%
Survival Time
12%
Carcinoma Cell
12%
Recombinant
12%
Pharmacology, Toxicology and Pharmaceutical Science
Adenoviridae
100%
Ovary Carcinoma
100%
Ovary Tumor
50%
Tumor Growth
37%
Green Fluorescent Protein
25%
Infection
12%
Neoplasm
12%
SCID Mouse
12%
Survival Time
12%
Vasculotropin Receptor 1
12%
Recombinant
12%
Tumor Model
12%
BALB/c Nude Mouse
12%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Adenoviridae
100%
Tumor Progression
37%
Green Fluorescent Protein
25%
Cell Proliferation
12%
Tyrosine Kinase Receptor
12%
Recombinant
12%
Survival Time
12%
SCID Mouse
12%
BALB/c Nude Mouse
12%